Jump to Navigation

April 2012 Archives

Actos Lawsuit Alleges Drugmaker Was Aware of Adverse Effects

A recent whistleblower lawsuit alleges that drugmaker Takeda Pharmaceutical Co. hid some of the adverse effects of its diabetes-drug Actos from federal regulators. The whistleblower alleges that the company was aware of a link between its dangerous prescription drug and hundreds of congested heart failure cases but opted not to report these events in the U.S. Food and Drug Administration's Adverse Event Reporting System.

Medication Errors Linked to Wrongful Deaths, Injuries

A study into prescription errors indicates that medication errors are shockingly common and often lead to the wrongful death of patients. One study of Canadian hospitals found that one in 13 patients suffered from a medical malpractice and that a quarter of these medical errors were drug-related.

Study: Poor Patients Less Likely to File Medmal Claims

A recently released study indicates that poorer patients are less likely to file medical malpractice claims than wealthier patients. The study, which was published in Clinical Orthopaedics and Related Research, goes against the belief of some physicians that lower income patients are more likely to complain about the care that they receive.

Employment Laws Violated by Employers

California is among the states that see a higher-than-average number of federal class actions brought under the Fair Labor Standards Act (FLSA) and these types of cases outnumber all other private class actions in this area of the law. Surprisingly, many of the FLSA and other employment cases stem from a lack of knowledge and compliance with employment laws by employers.

Lawsuits fight global warming on behalf of young people

Water is a big deal in California. Consequently, there is an entire sub-specialty of California law dealing with water and other environmental issues, based in part on the notion that natural resources belong to everyone. This was bolstered by a 1983 U.S. Supreme Court decision in a California case that the government has a duty to protect the "people's common heritage" under the public trust doctrine.

Company Sells Product Despite FDA Rejection

Rejection by the United States Food and Drug Administration was not enough to stop one company from selling a product outside the U.S. The well-known company Johnson & Johnson continued to sell its defective DePuy hip implant overseas, including in Europe, despite the FDA ban on the sale of this device in the United States because of safety concerns. Because regulations overseas can differ significantly from those in the United States, the company can say that it operated fully within the law.

Print this Page FindLaw Network
GK Results

The law firm of Girardi | Keese has successfully recovered in excess of $3 Billion on behalf of our clients.
The following cases are just a small sampling of the many successful cases G&K has achieved over the years:

$4.85 billion

Settlement with Merck, a major pharmaceutical company, for personal injuries to consumers of the drug Vioxx.

$633 million

Settlements with PG&E for toxic tort injury claims by residents of Hinkley, California (made famous by the film Erin Brockovich).

$1.9 billion

Settlement with Sempra Energy on behalf of California consumers who were defrauded by the manipulation of natural gas prices.

See More GK Results

Privacy Policy | Business Development Solutions by FindLaw, a Thomson Reuters business.

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close